SMARCA4 and neoplasm: Concerning tumor suppressor activity, BRG1-containing complexes regulate cellular proliferation by activating retinoblastoma protein through its hypophosphorylation, as mediated by the upregulation of CDK inhibitor p21 [47] (Figure 1b).